132 related articles for article (PubMed ID: 10658365)
21. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
22. [Skin infections after transplantation].
Wolf IH
Hautarzt; 2010 Mar; 61(3):230-3. PubMed ID: 20165826
[TBL] [Abstract][Full Text] [Related]
23. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
24. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
25. Fungal infections in nontransplant patients with hematologic malignancies.
Segal BH; Bow EJ; Menichetti F
Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and prevention of viral infections in patients with hematologic malignancies.
Angarone M
Infect Disord Drug Targets; 2011 Feb; 11(1):27-33. PubMed ID: 21303338
[TBL] [Abstract][Full Text] [Related]
27. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies.
Toubai T; Tanaka J; Ota S; Shigematsu A; Shono Y; Ibata M; Hashino S; Kondo T; Kakinoki Y; Masauzi N; Kasai M; Iwasaki H; Kurosawa M; Asaka M; Imamura M
Intern Med; 2007; 46(1):3-9. PubMed ID: 17202726
[TBL] [Abstract][Full Text] [Related]
29. Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.
Schulenburg A; Sperr W; Rabitsch W; Knöbl P; Thalhammer F
Leuk Lymphoma; 2005 Aug; 46(8):1163-7. PubMed ID: 16085557
[TBL] [Abstract][Full Text] [Related]
30. [Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Salavert M; Calabuig E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():36-47. PubMed ID: 21477703
[TBL] [Abstract][Full Text] [Related]
31. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
32. [Prophylaxis and treatment of fungal infections in oncohematological patients].
;
Rev Esp Quimioter; 2002 Dec; 15(4):387-401. PubMed ID: 12607556
[No Abstract] [Full Text] [Related]
33. Infections of febrile neutropenic patients in malignant hematological diseases.
Rókusz L; Liptay L
Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
[TBL] [Abstract][Full Text] [Related]
34. Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer.
González-Barca E; Carratalà J; Mykietiuk A; Fernández-Sevilla A; Gudiol F
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):117-9. PubMed ID: 11305464
[TBL] [Abstract][Full Text] [Related]
35. Mucocutaneous lesions in transplant recipient in a tropical country.
Prakash J; Singh S; Prashant GK; Kar B; Tripathi K; Singh PB
Transplant Proc; 2004 Sep; 36(7):2162-4. PubMed ID: 15518786
[TBL] [Abstract][Full Text] [Related]
36. [CUTANEOUS INFECTIONS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCIES].
Piérard GE
Rev Med Liege; 2015 Dec; 70(12):617-22. PubMed ID: 26867306
[TBL] [Abstract][Full Text] [Related]
37. Recent therapeutic advances in hematological malignancies: dealing with treatment-related complications.
Ludwig H; Zojer N
Ann Oncol; 2008 Jul; 19 Suppl 5():v71-8. PubMed ID: 18611905
[No Abstract] [Full Text] [Related]
38. [Infectious complications in elderly with chronic hematological malignancies].
Berlier C; Erard V
Rev Med Suisse; 2013 Oct; 9(401):1821-6. PubMed ID: 24191416
[TBL] [Abstract][Full Text] [Related]
39. Reduction of systemic fungal infections in patients with hematological malignancies, neutropenia, and prolonged fever by early amphotericin B therapy.
Zimmermann-Hösli MB; Stahel RA; Vogt P; Oelz O
Klin Wochenschr; 1988 Oct; 66(20):1010-4. PubMed ID: 3236752
[TBL] [Abstract][Full Text] [Related]
40. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
